Skip to main content
OpenTrials

Clinical trial condition

Cerebral Small Vessel Diseases

Explore clinical trials studying Cerebral Small Vessel Diseases. Study availability and eligibility vary by location and protocol.

282 public trials 64 recruiting studies
Refine in advanced search Browse all conditions

Cerebral Small Vessel Diseases trial results

Completed

Open Label Extension Study of 1 mg/kg Pegunigalsidase Alfa Every 2 Weeks in Patients With Fabry Disease

NCT03566017

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +29 more
Locations
  • UAB Medicine Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • University of California San Diego La Jolla, California, United States
  • University of California Irvine Center Orange, California, United States
View all 30 locations
View Trial Details
Completed

Early Detection of Fabry Disease

NCT05106764

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Universitätsklinikum Erlangen Kinder- und Jugendklinik Erlangen, Germany
  • Universitätsklinikum Erlangen Neurologische Klinik Erlangen, Germany
  • Universitätsklinikum Giessen Giessen, Germany
View Trial Details
Completed

Switch Over Study of Biosimilar Agalsidase Beta for Fabry Disease

NCT05843916

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Instituto de Nefrología Pergamino S.R.L Pergamino, Buenos Aires, Argentina
  • Centro Médico Santa María de la Salud San Isidro, Buenos Aires, Argentina
  • Instituto de Investigaciones Clínicas Quilmes Buenos Aires, Argentina
  • Clínica Universitaria Reina Fabiola Córdoba, Argentina
View Trial Details
Completed

Safety, Pharmacodynamics, and Efficacy of Migalastat in Pediatric Subjects (Aged >12 Years) With Fabry Disease

NCT04049760

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • University of South Florida Tampa, Florida, United States
  • The Emory Clinic Atlanta, Georgia, United States
  • University of Minnesota Masonic Children's Hospital and Clinics Minneapolis, Minnesota, United States
  • Cincinnati Children's Hospital Cincinnati, Ohio, United States
View Trial Details
Completed

A Study to Describe the Experience of Both Patients and Their Clinicians in the Treatment of Fabry Disease With Enzyme Replacement Therapy.

NCT04281537

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Amicus Therapeutics, Inc. Philadelphia, Pennsylvania, United States
  • Instituto de Genética e Erros Inatos do Metabolismo (IGEIM) São Paulo, Brazil
  • Keio University Hospital Tokyo, Japan
  • Yokohama Municipal Citizen's Hospital Yokohama, Japan
View Trial Details
Completed

OMT-28 in Patients With Primary Mitochondrial Disease (PMD) (PMD-OPTION)

NCT05972954

Conditions
Acid-Base Imbalance, Acidosis, Acidosis, Lactic, +44 more
Locations
  • Universitätsklinikum Bonn, Sektion Neuromuskuläre Erkrankungen, Klinik und Poliklinik für Neurologie, Venusberg-Campus 1, Gebäude 80, NPP Bonn, Germany
  • Medizinisch Fakultät der Martin-Luther-Universität Halle-Wittenberg Universitätsklinik und Poliklinik für Neurologie Universitätsklinikum , Ernst-Grube-Str. 40 Halle, Germany
  • Friedrich-Baur-Institut an der Neurologischen Klinik und Poliklinik, Klinikum der Universität München, Ludwig-Maximilians-Universität (LMU Klinikum), Ziemssenstr. 1a Munich, Germany
  • IRCCS Institute of Neurological Science of Bologna, University of Bologna, Department of Biomedical and Neuromotor Science (DIBINEM), Ospedale Bellaria Via Altura, 3 Bologna, Italy
View Trial Details
Completed

Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis

NCT03482479

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Aortic Arch Syndromes, Aortic Diseases, +33 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Safety Study for Previously Treated Vatiquinone (PTC743) Participants With Inherited Mitochondrial Disease

NCT05218655

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brain Diseases, +36 more
Locations
  • University of California, San Diego Altman Clinical and Translational Research Institute La Jolla, California, United States
  • Stanford University Stanford, California, United States
  • Yale Medicine New Haven, Connecticut, United States
  • Children's National Washington D.C., District of Columbia, United States
View all 26 locations
View Trial Details

Related conditions